Authors
Latest:
Economic Model Comparing Rivaroxaban and Enoxaparin for Post-Orthopedic VTE ProphylaxisThis analysis evaluates-from a US payer's perspective-the economic impact of using rivaroxaban versus enoxaparin for thromboprophylaxis following total hip or knee replacement surgery.
Latest:
Trends That Will Affect Specialty Health Care Into the FutureÂCurrent developments and innovations that will shape the future of specialty pharmacy.
Latest:
The Benefits of the Hub for Specialty PatientsPharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.
Latest:
Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia InclusionEvidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.
Latest:
The Road to WellnessA chain pharmacy implements an integrated care program featuring pharmacists and health care coaches who provide in-store counseling.
Latest:
Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's ContractureA retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.
Latest:
Point-of-Care Testing Offers New OpportunitiesConsider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.
Latest:
Safe Handling of Oral Chemo Agents in Community SettingsDr. Goodin is the director of the division of pharmaceutical sciences at the Cancer Institute of New Jersey and associate professor of medicine, division of medical oncology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick.
Latest:
Quantitative Analysis of 2 Treatment Options for Osteoarthritis in Adults: Intra-Articular Hyaluronan Products and DiacereinEmpirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.
Latest:
White-Coat Hypertension: A Closer LookEverything you need to know about WCH from diagnosis, treatment, and a review of the literature.
Latest:
Pain Management: Non-Opioid MedicationsGiven the disadvantages of opioids, including side effects and potential for addiction, non-opioid medications play an important role in pain management.
Latest:
Nutrition Counseling for Patients with Prediabetes or DiabetesMore than 86 million Americans over the age of 20 have prediabetes, 29 million Americans are diagnosed with diabetes, and another 8.1 million Americans are living with undiagnosed diabetes.
Latest:
What is the Current Status of Bioingestible Sensors for Medication Adherence?Sensors that can be attached to insulin pens, smart auto-injectors for patients with MS, sensors for inhalers, smart pill bottles, and bioingestible sensors are some of the evolving technologies.
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
Pharmacist Feature Friday: My Journey into Specialty PharmacyMaking the patients’ lives easier is at the heart of my job.
Latest:
Infection Specialists and Pharmacists Share Responsibility for Ensuring Patient SafetyCollaboration Is a necessary component of successful compliance with USP , and technology can help.
Latest:
“NASP in Action” Highlights Organization’s Efforts to Elevate Specialty PharmacyA session during the National Association of Specialty Pharmacy (NASP) 2020 Annual Meeting & Expo Virtual Experience, held September 14 to 18, 2020, highlighted some of the nonprofit’s activities.
Latest:
High-Value Medications: Preserving Value after a Frosty FlounderThe pharmaceutical industry continually develops novel therapeutics, many of which require refrigeration and are associated with high costs. In the event of such temperature excursions as a breach in the cold chain protocol, pharmacists are looked upon as experts who can deter- mine whether medications are still viable.
Latest:
Evaluation of Dual Versus Triple Therapy for Hepatitis CIn this retrospective chart review, patients with hepatitis C had a sustained virologic response with either dual or triple therapy.
Latest:
Strategies to Improve PBM Management of an Employee Prescription Drug PlanDescription of strategies that employers can consider to better manage their PBM relationship to optimize their pharmacy benefit costs.
Latest:
Cost-Effectiveness of Extended-Release Carbidopa-Levodopa for Advanced Parkinson's DiseaseExisting levodopa therapies for Parkinson’s disease often provide inadequate symptom control after prolonged treatment. This study assessed the cost-effectiveness of an extended-release carbidopa-levodopa formulation (IPX066).
Latest:
Managing COVID-19 at Home: A ToolboxHelpful patient education suggestions for the successful management of COVID-19 at home and when it is appropriate to seek medical attention.
Latest:
Key Points From the 2016 NIOSH List of Antineoplastic and Hazardous Drugs in Health Care SettingsChemotherapy, antivirals, and hormone therapies are among the drugs addressed in the 2016 National Institute for Occupational Safety and Health list.
Latest:
Impact of Insulin Delivery Systems in Elderly Patients With Type 2 DiabetesThis real-world study suggests that improved clinical outcomes are possible in the difficult-to-treat elderly patients with type 2 diabetes group without affecting healthcare costs, by initiating insulin therapy with a pen device.
Latest:
Hit Me With Your Best Shot: Rabies Pre-exposure VaccinationPrEP simplifies management of the virus by eliminating the need for immune globulin and decreasing the number of doses needed.
Latest:
Determinants of Primary Nonadherence in Asthma-Controller and Dyslipidemia PharmacotherapyThis study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.
Latest:
A Linezolid Prior Authorization Program: Clinical and Economic OutcomesThis study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Latest:
Vivitrol Is Making Its Way to Retail PharmaciesThis extended-release injectable suspension aims to prevent relapse in opioid-dependent patients after detox and treat alcoholism.
